Viridian Therapeutics, Inc.
VRDN
$30.43
-$1.02-3.24%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 490.90M | 563.36M | 636.63M | 717.58M | 753.24M |
| Total Receivables | 70.00M | -- | -- | -- | 14.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 11.01M | 15.39M | 20.61M | 20.88M | 14.10M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 571.91M | 578.75M | 657.24M | 738.46M | 767.36M |
|
|
|||||
| Total Current Assets | 571.91M | 578.75M | 657.24M | 738.46M | 767.36M |
| Net Property, Plant & Equipment | 3.71M | 3.07M | 3.25M | 3.44M | 3.69M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 1.52M | 506.00K | 489.00K | 501.00K | 853.00K |
| Total Assets | 577.14M | 582.32M | 660.98M | 742.40M | 771.90M |
|
|
|||||
| Total Accounts Payable | 10.06M | 8.52M | 3.89M | 2.14M | 6.34M |
| Total Accrued Expenses | 39.53M | 34.79M | 28.92M | 44.83M | 34.05M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 730.00K | 8.99M | 536.00K | 513.00K | 589.00K |
| Total Finance Division Other Current Liabilities | 372.00K | 288.00K | 388.00K | 388.00K | 388.00K |
| Total Other Current Liabilities | 372.00K | 288.00K | 388.00K | 388.00K | 388.00K |
| Total Current Liabilities | 50.70M | 52.59M | 33.73M | 47.87M | 41.36M |
|
|
|||||
| Total Current Liabilities | 50.70M | 52.59M | 33.73M | 47.87M | 41.36M |
| Long-Term Debt | 20.89M | 12.35M | 20.69M | 20.58M | 20.52M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 2.58M | 1.74M | 1.88M | 2.02M | 2.16M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | 477.00K | 212.00K | 284.00K | 356.00K |
| Total Liabilities | 74.17M | 67.16M | 56.51M | 70.76M | 64.40M |
|
|
|||||
| Common Stock & APIC | 1.53B | 1.51B | 1.50B | 1.48B | 1.43B |
| Retained Earnings | -1.22B | -1.18B | -1.08B | -995.86M | -916.13M |
| Treasury Stock & Other | 363.00K | 69.00K | 245.00K | -10.00K | 932.00K |
| Total Common Equity | 314.09M | 326.28M | 415.59M | 482.75M | 518.61M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | 188.89M | 188.89M | 188.89M | 188.89M | 188.89M |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 188.89M | 188.89M | 188.89M | 188.89M | 188.89M |
|
|
|||||
| Total Common Equity | 314.09M | 326.28M | 415.59M | 482.75M | 518.61M |
| Total Preferred Equity | 188.89M | 188.89M | 188.89M | 188.89M | 188.89M |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 502.97M | 515.17M | 604.47M | 671.64M | 707.50M |
|
|
|||||